Literature DB >> 2170112

The physical organization of the human immunoglobulin heavy chain gene complex.

M A Walter1, U Surti, M H Hofker, D W Cox.   

Abstract

Two dimensional DNA electrophoresis (2D-DE) was used to map the variable (VH) region of the human heavy chain immunoglobulin gene cluster. Seventy-six VH gene segments were mapped to specific SfiI, BssHI and NotI fragments by 2D-DE. We have determined that a common insertion/deletion polymorphism of 80 kb, involving three VH gene segments, occurs in the VH region. The physical map suggests that the evolution of the human IGH gene complex involved duplication of blocks containing different VH families. This physical map will allow comparison of the usage of VH loci in human ontogeny with their proximity to the CH region. Knowledge of the germline repertoire of a particular DNA source studied in essential as the number of the dispersed VH gene segments of VH families, especially of the VH5 family, is variable. 2D-DE, as illustrated here for the IGH gene cluster, has general application in the development of large scale physical maps of gene and repeat families.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170112      PMCID: PMC552067          DOI: 10.1002/j.1460-2075.1990.tb07530.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  47 in total

1.  Developmentally controlled expression of immunoglobulin VH genes.

Authors:  R M Perlmutter; J F Kearney; S P Chang; L E Hood
Journal:  Science       Date:  1985-03-29       Impact factor: 47.728

2.  Analysis of genetic variation reveals human immunoglobulin VH-region gene organization.

Authors:  M A Walter; D W Cox
Journal:  Am J Hum Genet       Date:  1988-03       Impact factor: 11.025

3.  Preferential utilization of the most JH-proximal VH gene segments in pre-B-cell lines.

Authors:  G D Yancopoulos; S V Desiderio; M Paskind; J F Kearney; D Baltimore; F W Alt
Journal:  Nature       Date:  1984 Oct 25-31       Impact factor: 49.962

4.  Diversity and joining segments of mouse immunoglobulin heavy chain genes are closely linked and in the same orientation: implications for the joining mechanism.

Authors:  C Wood; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

5.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  Restriction fragment length polymorphisms associated with immunoglobulin C gamma genes reveal linkage disequilibrium and genomic organization.

Authors:  N T Bech-Hansen; P S Linsley; D W Cox
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

7.  Translocation of immunoglobulin VH genes in Burkitt lymphoma.

Authors:  J Erikson; J Finan; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

8.  Structure and multiplicity of genes for the human immunoglobulin heavy chain variable region.

Authors:  G Matthyssens; T H Rabbitts
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

9.  Polymorphisms of a human variable heavy chain gene show linkage with constant heavy chain genes.

Authors:  M J Johnson; A M Natali; H M Cann; T Honjo; L L Cavalli-Sforza
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

10.  Multiple DNA fragment polymorphisms associated with immunoglobulin mu chain switch-like regions in man.

Authors:  N Migone; J Feder; H Cann; B van West; J Hwang; N Takahashi; T Honjo; A Piazza; L L Cavalli-Sforza
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

View more
  27 in total

1.  Direct detection of insertion/deletion polymorphisms in an autosomal region by analyzing high-density markers in individual spermatozoa.

Authors:  Sreemanta Pramanik; Honghua Li
Journal:  Am J Hum Genet       Date:  2002-11-19       Impact factor: 11.025

2.  Germline variable region gene segment derivation of human monoclonal anti-Rh(D) antibodies. Evidence for affinity maturation by somatic hypermutation and repertoire shift.

Authors:  J M Bye; C Carter; Y Cui; B D Gorick; S Songsivilai; G Winter; N C Hughes-Jones; J D Marks
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

3.  The study of minimal residual disease in acute lymphoblastic leukaemia.

Authors:  C J Knechtli; N J Goulden; K Langlands; M N Potter
Journal:  Clin Mol Pathol       Date:  1995-04

4.  A deletion map of the human immunoglobulin heavy chain variable region.

Authors:  M A Walter; H M Dosch; D W Cox
Journal:  J Exp Med       Date:  1991-08-01       Impact factor: 14.307

5.  Determination of gene organization in individual haplotypes by analyzing single DNA fragments from single spermatozoa.

Authors:  X Cui; H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

6.  VHDJH gene sequences and antigen reactivity of monoclonal antibodies produced by human B-1 cells: evidence for somatic selection.

Authors:  E W Schettino; S K Chai; M T Kasaian; H W Schroeder; P Casali
Journal:  J Immunol       Date:  1997-03-01       Impact factor: 5.422

Review 7.  VH-mediated mechanisms in normal and neoplastic B cell development.

Authors:  L E Silberstein; S P Rao
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

8.  Lack of intraclonal diversification in Ig heavy and light chain V region genes expressed by CD5+IgM+ chronic lymphocytic leukemia B cells: a multiple time point analysis.

Authors:  E W Schettino; A Cerutti; N Chiorazzi; P Casali
Journal:  J Immunol       Date:  1998-01-15       Impact factor: 5.422

9.  Expression of the immunoglobulin VH gene 51p1 is proportional to its germline gene copy number.

Authors:  E H Sasso; T Johnson; T J Kipps
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

10.  Molecular analysis redefines three human chromosome 14 deletions.

Authors:  R F Wintle; T Costa; R H Haslam; I E Teshima; D W Cox
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.